Laurie joined MC Services in 2016 and has 25 years of investor relations and corporate communications experience. Prior to joining MC Services, Laurie led US IR and corporate communications at the French biotech, Transgene. She previously served as head of IR and corporate communications for immunotherapy company, Agennix, and led US IR and corporate communications for the oncology company, GPC Biotech. She began her IR career at Organogenesis, a tissue engineering firm. She has spearheaded a wide range of initiatives, including raising awareness and understanding of the companies for which she worked in the investment community and press. She has led IR and PR activities around a variety of major news events, including Phase III data readouts, M&A and leadership change, and has been a key team member for major financings, including a Nasdaq listing. Laurie has an MBA from Simmons University and a BA in Russian from Middlebury College.